Raymond James Reinstates Outperform on Omega Healthcare Invts, Announces $50 Price Target
Benzinga Newsdesk 4 months ago
NewsPrice TargetInitiationAnalyst Ratings
Raymond James analyst David Rodgers reinstates Omega Healthcare Invts (NYSE:OHI) with a Outperform and announces $50 price target.
Raymond James analyst David Rodgers reinstates Omega Healthcare Invts (NYSE:OHI) with a Outperform and announces $50 price target.